Procept Biorobotics saw the highest growth of 99% in patent filings and 49% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 99% and grants by 49%. GlobalData’s DataBook provides a comprehensive analysis of Procept Biorobotics‘s patent filings and grants. Buy the databook here.
Procept Biorobotics has been focused on protecting inventions in United States(US) with two publications in Q4 2023
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 100% grants. The United States(US), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Procept Biorobotics is filings its patents. Among the top granted patent authorities, Procept Biorobotics has 100% of its grants in United States(US)
Teleflex and Koninklijke Philips could be the strongest competitors for Procept Biorobotics
See Also:
In terms of grant share, Procept Biorobotics stands first among its competitors followed by Teleflex and Koninklijke Philips.
Patents related to healthtech and computer vision lead Procept Biorobotics's portfolio
Procept Biorobotics has the highest number of patents in healthtech followed by, computer vision. For healthtech, nearly 100% of patents were filed and 50% of patents were granted in Q4 2023.
Diagnostic imaging related patents lead Procept Biorobotics portfolio followed by general surgery devices, and industrial automation
Procept Biorobotics has highest number of patents in diagnostic imaging followed by general surgery devices, industrial automation.
For comprehensive analysis of Procept Biorobotics's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.